Description
Latin name
Ixel
Release form
Capsules
packaging 56 pcs
Indications
Depressive disorders of varying severity.
Contraindications
Absolute
children and adolescents under 15
hypersensitivity to the drug
simultaneous administration of non-selective and selective MAO type B inhibitors
simultaneous administration of selective serotonin reuptake inhibitors (sumatriptan).
Relative
simultaneous administration with adrenaline, norepinephrine, clonidine and its derivatives
benign prostatic hyperplasia and urinary tract obstruction of a different origin
pregnancy
lactation (breastfeeding).
Special instructions
With caution, prescribe the drug to patients with a history of convulsive seizures, with hypertension, cardiomyopathy.
Ixel can be assigned no earlier than 14 days after discontinuation of MAO inhibitors. In addition, from the moment of discontinuation of the drug Xel to the start of therapy with MAO inhibitors, at least 7 days must elapse.
A gradual increase in the dose of the drug is recommended to reduce the severity of side effects.
When conducting local anesthesia with drugs containing adrenaline or norepinephrine during therapy with IxelВ® therapy, the dose of anesthetics should not exceed 0.1 mg per 10 min and 0.3 mg per 1 hour.
Do not drink alcohol during treatment with Ixel.
Influence on the ability to drive and control mechanisms
During the period of use of the drug should refrain from engaging in potentially hazardous activities that require increased attention and rapid psychomotor reactions.
Composition
1 capsule contains:
Active ingredient: milnacipran hydrochloride 25 mg
Dosage and administration
The average daily dose is 100 mg, the drug should be taken in 2 divided doses in the morning. Depending on the severity of symptoms, the dose may be increased to 250 mg.
The drug is preferably taken with food.
Duration of therapy is set individually.
In patients with renal failure, a dose reduction is necessary depending on the creatinine clearance values.
Side effects
From the central nervous system: a sense of anxiety, dizziness rarely – tremor.
From the digestive system: rarely – dry mouth, nausea, vomiting, constipation in isolated cases – a moderate increase in transaminase activity.
Other: rarely – palpitations, increased sweating, hot flashes, difficulty urinating in isolated cases – serotonergic syndrome.
Side effects are rare, mainly during the first 2 weeks of therapy, usually stop on their own as regression of depressive symptoms and do not require discontinuation of the drug.
Drug Interactions
With the simultaneous use of Ixel with MAO inhibitors, sumatriptan, lithium preparations there is a danger of developing serotonergic syndrome.
The simultaneous use of Ixel with adrenaline and norepinephrine can provoke the development of a hypertensive crisis and cardiac arrhythmias.
When taken with digoxin (especially with parenteral administration), there is a risk of potentiation of hemodynamic disorders.
With the simultaneous use of Ixel inhibits the hypotensive effect of clonidine and its derivatives.
Overdose
Symptoms: if you accidentally increase your dose – nausea, vomiting, sweating, constipation. When taking the drug in a dose exceeding 800-1000 mg – vomiting, difficulty breathing, tachycardia. After taking at an excessively high dose (1900-2800 mg milnacipran) in combination with other psychotropic drugs (most often benzodiazepines), drowsiness, hypercapnia, and disorders of consciousness are added to the symptoms described above.
Treatment: gastric lavage, symptomatic therapy. Medical monitoring of the patient’s condition for at least 24 hours is recommended. There is no specific antidote.
Storage Conditions
The product should be stored in a dry, cool place at a temperature not exceeding 30 °.
Shelf life
3 years.
Deystvuyushtee substance
Milnacipran
Terms and conditions
prescription
Dosage form
capsules
Possible product names
IKSEL 0,025 N56 CAPS
Ixel 25mg Caps. X56
Ixel 25mg Caps. X56 / until 12.09 /
Ixel 25mg No. 56
IKSEL KAPS. 25MG N56
